Johnson & Johnson : Reports 2011 Fourth-Quarter and Full-Year Results – 4-traders (press release)

Sales results in the U.S. were negatively impacted by generic competition for LEVAQUIN® (levofloxacin), a treatment for bacterial infections, which was offset by the strong performance of recently launched products. The strong performance of recently …

Leave a Reply

Your email address will not be published.

*